Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Enochian Biosciences Inc. (ENOB)

5.53   -0.19 (-3.32%) 01-19 08:05
Open: 5.75 Pre. Close: 5.72
High: 5.75 Low: 5.46
Volume: 220,437 Market Cap: 289M
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.762 - 5.797 5.797 - 5.823
Low: 5.38 - 5.424 5.424 - 5.457
Close: 5.471 - 5.537 5.537 - 5.586

Technical analysis

as of: 2022-01-18 4:30:51 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 10.42     One year: 12.96
Support: Support1: 5.40    Support2: 4.49
Resistance: Resistance1: 8.92    Resistance2: 11.10
Pivot: 6.69
Moving Average: MA(5): 5.95     MA(20): 7.03
MA(100): 8.39     MA(250): 5.96
MACD: MACD(12,26): -0.89     Signal(9): -0.80
Stochastic oscillator: %K(14,3): 6.42     %D(3): 6.43
RSI: RSI(14): 25.06
52-week: High: 13.78  Low: 2.86  Change(%): 68.6
Average Vol(K): 3-Month: 25088  10-Days: 19010

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ENOB has closed above bottom band by 4.7%. Bollinger Bands are 1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 20 Dec 2021
Enochian Biosciences Inc (ENOB) Stock: What Does the Chart Say Monday? - InvestorsObserver

Fri, 29 Oct 2021
Enochian Biosciences (NASDAQ:ENOB) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Mon, 18 Oct 2021
Enochian BioSciences Announces the Successful Completion of - GlobeNewswire

Tue, 12 Oct 2021
Fireside Chat with Enochian BioSciences' CEO, Dr. Mark Dybul at HC Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference - GlobeNewswire

Mon, 30 Aug 2021
Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences’ Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants - Yahoo Finance

Sat, 26 Jun 2021
Enochian Biosciences: A Follow Through For An HIV Cure - Seeking Alpha

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 52
Shares Float (M) 17
% Held by Insiders 61.07
% Held by Institutions 2.95
Shares Short (K) 1,580
Shares Short P. Month (K) 670

Stock Financials

EPS -0.670
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.200
Profit Margin
Operating Margin
Return on Assets (ttm) -9.8
Return on Equity (ttm) -21.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.535
Qtrly Earnings Growth
Operating Cash Flow (M) -23
Levered Free Cash Flow (M) -13

Stock Valuations

PE Ratio -8.25
PEG Ratio
Price to Book value 1.73
Price to Sales
Price to Cash Flow -12.48

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.